Seeing Is Believing

Currently out of the existing stock ratings of Edward Tenthoff, 816 are a BUY (91.38%), 70 are a HOLD (7.84%), 7 are a SELL (0.78%).
Analyst Edward Tenthoff, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 53.78% that have a potential upside of 55.28% achieved within 356 days.
Edward Tenthoff’s has documented 1,700 price targets and ratings displayed on 97 stocks. The coverage is on Healthcare, Technology, Industrials, Energy, Consumer Cyclical, Basic Materials sectors.
Most recent stock forecast was given on MRNA, Moderna at 26-Jun-2026.
Analyst best performing recommendations are on SKYE (SKYE BIOSCIENCE, COMMON STOCK).
The best stock recommendation documented was for AVEO (AVEO PHARMACEUTICALS) at 6/23/2017. The price target of $20 was fulfilled within 4 days with a profit of $7.5 (60%) receiving and performance score of 150.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Aug-2023
$12
$-15.6 (-56.52%)
$12.5
2 years 8 months 4 days ago
(13-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
10
Buy Since 25-Jul-2023
$23
$-4.6 (-16.67%)
$22.5
2 years 8 months 24 days ago
(23-Oct-2023)
2/2 (100%)
$10.59 (85.33%)
120
Hold Since 03-Mar-2023
3 years 4 months 14 days ago
(03-Mar-2023)
0/3 (0%)
$161.25 (75.44%)
Buy Since 27-Oct-2022
$25
3 years 8 months 20 days ago
(27-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy Since 04-Feb-2022
4 years 1 months 14 days ago
(03-Jun-2022)
3/3 (100%)
$-30.5 (-77.22%)
161
Which stock is Edward Tenthoff is most bullish on?
Which stock is Edward Tenthoff is most reserved on?
What Year was the first public recommendation made by Edward Tenthoff?